Yasunobu Kai
Direktor/Vorstandsmitglied bei H3 Biomedicine, Inc.
Profil
Yasunobu Kai is currently a Director at H3 Biomedicine, Inc. He previously worked as an Executive Officer & Chief Strategy Officer at Eisai Co., Ltd.
Aktive Positionen von Yasunobu Kai
Unternehmen | Position | Beginn |
---|---|---|
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yasunobu Kai
Unternehmen | Position | Ende |
---|---|---|
EISAI CO., LTD. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EISAI CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |